Little Remedies Noses Saline Spray Drops, 1 Fl Oz

Description

Little Remedies Saline Nasal Spray and Drops provide relief from stuffy noses and are the number one pediatrician-recommended children’s nasal spray brand.* This baby saline nasal spray and drops temporarily relieve stuffy, dry, or crusty noses and keep your baby's nose clear and moisturized. This nose spray flushes mucus from little ones’ noses, providing a nasal rinse that can be used as a dropper or as a soft spray to help your baby breathe easier. Little Remedies Nasal Saline Spray and Drops contain no alcohol and are drug-free and preservative-free. This non-medicated saline spray can help with your kid’s cold and allergy symptoms and can even be used as saline nose drops for newborns. This baby saline nasal spray and nasal drops can be used as often as needed without the worry of any harmful side effects or drug interactions. As a parent, it's the little things that matter. Your baby's little giggles, little steps, and little sniffles. Being there with a little hug and a little song. Loving touches and attention to detail go into everything you do. Little things matter to us, too. Little Remedies designs safe and reliable solutions just for babies. To help your baby stay happy, we make sure they have everything they need and nothing they don't. *IQVIA, using the ProVoice Survey, from December 1, 2022 to November 30, 2023. Little Remedies, Saline Nasal Spray, Newborn Nose Drops are both FSA-eligible and HSA-eligible in the U.S.

Key Features

• •Little Remedies Sterile Saline Nasal Spray and Drops temporarily clears stuffy, dry, or crusty noses and keep baby's nose clear and moisturized
• •Baby saline nasal spray flushes mucus from little ones’ noses
• •Nasal saline spray and drops contain no alcohol and are drug- and preservative-free
• •Non-medicated saline can be used as a dropper or gentle spray for kids' cold and allergy symptoms; Safe for newborns
• •Little Remedies is the number one pediatrician-recommended Children's Nasal Spray brand* *IQVIA, using the ProVoice Survey, from December 1, 2022 to November 30, 2023